{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:27Z","timestamp":1794852687563,"version":"4.9.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-025-02255-z","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T13:02:42Z","timestamp":1742130162000},"page":"959-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regional citrate anticoagulation for continuous renal replacement therapy: a prospective study\u00a0in a\u00a0resource-limited intensive care unit from Vietnam"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0761-0672","authenticated-orcid":false,"given":"Dai Quang","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Thi Thu","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8723-7964","authenticated-orcid":false,"given":"Ngan Hoang Kim","family":"Trieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Hoang","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hieu Trung","family":"Kieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-2390","authenticated-orcid":false,"given":"Thao Thi Ngoc","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Ngoc","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuoc","family":"Van Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,16]]},"reference":[{"key":"2255_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411\u20131423","journal-title":"Intensive Care Med"},{"issue":"10","key":"2255_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM et al (2018) Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 14(10):607\u2013625","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"2255_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MCC.0000000000000541","volume":"24","author":"AY Wang","year":"2018","unstructured":"Wang AY, Bellomo R (2018) Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy? Curr Opin Crit Care 24(6):437\u2013442","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"2255_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1542-4758.2007.00166.x","volume":"11","author":"KG Fischer","year":"2007","unstructured":"Fischer KG (2007) Essentials of anticoagulation in hemodialysis. Hemodial Int 11(2):178\u2013189","journal-title":"Hemodial Int"},{"issue":"Suppl 3","key":"2255_CR5","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.5005\/jp-journals-10071-23412","volume":"24","author":"S Singh","year":"2020","unstructured":"Singh S (2020) Anticoagulation during Renal Replacement Therapy. Indian J Crit Care Med 24(Suppl 3):S112\u2013S116","journal-title":"Indian J Crit Care Med"},{"issue":"9","key":"2255_CR6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/ckj\/sfad069","volume":"16","author":"P Thanapongsatorn","year":"2023","unstructured":"Thanapongsatorn P, Sinjira T, Kaewdoungtien P, Kusirisin P, Kulvichit W, Sirivongrangson P et al (2023) Standard versus no post-filter ionized calcium monitoring in regional citrate anticoagulation for continuous renal replacement therapy (NPC trial). Clin Kidney J 16(9):1469\u20131479","journal-title":"Clin Kidney J"},{"issue":"6","key":"2255_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/sdi.12959","volume":"34","author":"M Legrand","year":"2021","unstructured":"Legrand M, Tolwani A (2021) Anticoagulation strategies in continuous renal replacement therapy. Semin Dial 34(6):416\u2013422","journal-title":"Semin Dial"},{"issue":"1","key":"2255_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R (2011) Clinical review: anticoagulation for continuous renal replacement therapy\u2013heparin or citrate? Crit Care 15(1):202","journal-title":"Crit Care"},{"issue":"12","key":"2255_CR9","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2215\/CJN.01280214","volume":"9","author":"S Morabito","year":"2014","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E (2014) Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 9(12):2173\u20132188","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2255_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"Kellum JA, Lameire N, Group KAGW","year":"2013","unstructured":"Kellum JA, Lameire N, Group KAGW (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204","journal-title":"Crit Care"},{"issue":"1","key":"2255_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmele T (2017) Complications of regional citrate anticoagulation: accumulation or overload? Crit Care 21(1):281","journal-title":"Crit Care"},{"issue":"1","key":"2255_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","volume":"27","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P (2023) Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Crit Care 27(1):222","journal-title":"Crit Care"},{"issue":"1","key":"2255_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13613-021-00850-4","volume":"11","author":"P Koglberger","year":"2021","unstructured":"Koglberger P, Klein SJ, Lehner GF, Bellmann R, Peer A, Schwarzler D et al (2021) Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation. Ann Intensive Care 11(1):62","journal-title":"Ann Intensive Care"},{"issue":"1","key":"2255_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","volume":"19","author":"F Stucker","year":"2015","unstructured":"Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J et al (2015) Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care 19(1):91","journal-title":"Crit Care"},{"issue":"9","key":"2255_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1345\/aph.1M182","volume":"43","author":"LD Burry","year":"2009","unstructured":"Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D et al (2009) Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy. Ann Pharmcother 43(9):1419\u20131425","journal-title":"Ann Pharmcother"},{"issue":"1","key":"2255_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00134-011-2438-3","volume":"38","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Hongying N (2012) Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 38(1):20\u201328","journal-title":"Intensive Care Med"},{"issue":"12","key":"2255_CR17","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y et al (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41(12):2098\u20132110","journal-title":"Intensive Care Med"},{"issue":"1","key":"2255_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s44158-023-00091-w","volume":"3","author":"V Pistolesi","year":"2023","unstructured":"Pistolesi V, Morabito S, Pota V, Valente F, Di Mario F, Fiaccadori E et al (2023) Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission. J Anesth Analg Crit Care 3(1):7","journal-title":"J Anesth Analg Crit Care"},{"issue":"12","key":"2255_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.5301\/ijao.5000283","volume":"36","author":"S Morabito","year":"2013","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F et al (2013) Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Int J Artif Organs 36(12):845\u2013852","journal-title":"Int J Artif Organs"},{"issue":"1","key":"2255_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000453443","volume":"44","author":"V Pistolesi","year":"2017","unstructured":"Pistolesi V, Zeppilli L, Polistena F, Sacco MI, Pierucci A, Tritapepe L et al (2017) Preventing continuous renal replacement therapy-induced hypophosphatemia: an extended clinical experience with a phosphate-containing solution in the setting of regional citrate anticoagulation. Blood Purif 44(1):8\u201315","journal-title":"Blood Purif"},{"issue":"16","key":"2255_CR21","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D et al (2020) Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA 324(16):1629\u20131639. https:\/\/doi.org\/10.1001\/jama.2020.18618","journal-title":"JAMA"},{"issue":"6","key":"2255_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/1744-9987.13850","volume":"26","author":"R Li","year":"2022","unstructured":"Li R, Gao X, Zhou T, Li Y, Wang J, Zhang P (2022) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis of randomized controlled trials. Ther Apher Dial 26(6):1086\u20131097","journal-title":"Ther Apher Dial"},{"issue":"2","key":"2255_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","volume":"30","author":"M Monchi","year":"2004","unstructured":"Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 30(2):260\u20135","journal-title":"Intensive Care Med."},{"issue":"4","key":"2255_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s40620-020-00864-4","volume":"34","author":"F Di Mario","year":"2021","unstructured":"Di Mario F, Regolisti G, Greco P, Maccari C, Superchi E, Morabito S et al (2021) Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring. J Nephrol 34(4):1271\u20131279","journal-title":"J Nephrol"},{"issue":"1\u20133","key":"2255_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000440972","volume":"41","author":"M Zakharchenko","year":"2016","unstructured":"Zakharchenko M, Leden P, Rulisek J, Los F, Brodska H, Balik M (2016) Ionized magnesium and regional citrate anticoagulation for continuous renal replacement therapy. Blood Purif 41(1\u20133):41\u201347","journal-title":"Blood Purif"},{"issue":"2","key":"2255_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ckj\/sfv133","volume":"9","author":"G Godaly","year":"2016","unstructured":"Godaly G, Carlsson O, Broman M (2016) Phoxilium((R)) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy. Clin Kidney J 9(2):205\u2013210","journal-title":"Clin Kidney J"},{"issue":"7","key":"2255_CR27","doi-asserted-by":"publisher","first-page":"e0158179","DOI":"10.1371\/journal.pone.0158179","volume":"11","author":"M Zakharchenko","year":"2016","unstructured":"Zakharchenko M, Los F, Brodska H, Balik M (2016) The effects of high level magnesium dialysis\/substitution fluid on magnesium homeostasis under regional citrate anticoagulation in critically Ill. PLoS ONE 11(7):e0158179","journal-title":"PLoS ONE"},{"issue":"1","key":"2255_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ndt\/gfq575","volume":"26","author":"GR Hetzel","year":"2011","unstructured":"Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ et al (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26(1):232\u2013239","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2255_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13613-023-01113-0","volume":"13","author":"W Boer","year":"2023","unstructured":"Boer W, Verbrugghe W, Hoste E, Jacobs R, Jorens PG (2023) Unapparent systemic effects of regional anticoagulation with citrate in continuous renal replacement therapy: a narrative review. Ann Intensive Care 13(1):16","journal-title":"Ann Intensive Care"},{"issue":"4","key":"2255_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13054-014-0472-6","volume":"18","author":"L Schilder","year":"2014","unstructured":"Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG et al (2014) Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care 18(4):472","journal-title":"Crit Care"},{"issue":"2","key":"2255_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH et al (2014) Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care 29(2):265\u2013271","journal-title":"J Crit Care"},{"key":"2255_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092570","author":"F Mariano","year":"2023","unstructured":"Mariano F, Mella A, Randone P, Agostini F, Bergamo D, Berardino M et al (2023) Safety and metabolic tolerance of citrate anticoagulation in critically Ill polytrauma patients with acute kidney injury requiring an early continuous kidney replacement therapy. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11092570","journal-title":"Biomedicines."},{"issue":"12","key":"2255_CR33","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1093\/ndt\/gfr106","volume":"26","author":"F Mariano","year":"2011","unstructured":"Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M et al (2011) Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transpl 26(12):3882\u20133888","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"2255_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1744-9987.13471","volume":"24","author":"H Schiffl","year":"2020","unstructured":"Schiffl H (2020) Intensity of renal replacement therapy and outcomes in critically ill patients with acute kidney injury: Critical appraisal of the dosing recommendations. Ther Apher Dial 24(6):620\u2013627","journal-title":"Ther Apher Dial"},{"issue":"2","key":"2255_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"HM Oudemans-van Straaten","year":"2009","unstructured":"Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI et al (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37(2):545\u2013552","journal-title":"Crit Care Med"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-025-02255-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-025-02255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:59:19Z","timestamp":1777564759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/3\/959\/8457462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1007\/s40620-025-02255-z","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,16]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board approved this study on May 13, 2016, after the Ethics Committee in Biomedical Research of the University of Medicine and Pharmacy at Ho Chi Minh City (Number 149\/\u0110HYD-H\u0110) granted it. The study was performed following the ethical standards of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent or their legally authorized representatives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}}]}}